Shkreli, who hit the headlines last year after he hiked the price a life-saving drug often given to people with HIV or cancer from $13.50 to $750 a pill, is accused of defrauding investors in hedge funds he ran.
It’s not often given. There’s some 750 or so patients a year last I recall.
And the scandal here isn’t Shkreli, it’s the absurd FDA regulatory system which means he was able to game it as he did. It’s the FDA which needs the reform….